Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hFlt-3 Ligand. Anti-Human Flt-3 Ligand specific antibody was purified by affinity chromatography employing immobilized hFlt-3 Ligand matrix.
Form:
A sterile filtered antibody solution was lyophilized from PBS, pH 7.2.
Antibody Type:
Polyclonal Antibody
Application Notes:
WesternBlot: To detect hFlt-3 Ligand by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hFlt-3 Ligand is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.. Sandwich: To detect hFlt-3 Ligand by sandwich ELISA (using 100 µl/well antibody solution) a concentration of 0.5 - 2.0 µg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with BioGems Biotinylated Anti-Human Flt-3 Ligand (60-147BT) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hFlt-3 Ligand.. Neutralization: To yield one-half maximal inhibition [ND<span style=font-size: 16px,>50] of the biological activity of hFlt-3 Ligand (1.0 ng/ml), a concentration of 4.0-6.0 ng/ml of this antibody is required.. Reconstitution: Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml.
* VAT and and shipping costs not included. Errors and price changes excepted
